Research programme: anti-infectives - QuoNova
Alternative Names: QSB - QuoNova; Quorum sensing blockers - QuoNovaLatest Information Update: 16 Jul 2016
At a glance
- Originator QuoNova LLC
- Developer QuoNova
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections; Mycoses
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Mycoses in USA
- 07 Feb 2008 Preclinical trials in Bacterial infections in USA (unspecified route)